구강암 신속 검사 키트 시장 - 세계 규모, 점유율, 동향 분석, 기회, 예측 보고서(2019-2030년)

Global Oral Cancer Rapid Test Kit Market Size Expands at Significant CAGR of 6.03% to Touch Whopping USD 1.2 Billion by 2030

Global Oral Cancer Rapid Test Kit Market is flourishing because of the growing focus on investments in the development and adoption of diagnostic equipment and kits for oral cancer.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Oral Cancer Rapid Test Kit Market size at USD 987.76 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Oral Cancer Rapid Test Kit Market size to expand at a CAGR of 6.03% reaching a value of USD 1,184.23 million by 2030. The increased incidence of oral cancer as a result of rising tobacco and alcohol consumption and advancements in testing kits, such as those in biosensor technology, are key growth drivers for the Global Oral Cancer Rapid Test Kit Market. Moreover, it is projected that the Global Oral Cancer Rapid Test Kit Market will be driven by growing awareness that will result in more cancer screenings.

Opportunity: Expanding research and development programs

Governments, research institutions, and private companies are heavily investing in research and development activities to accurately diagnose cancer in response to the rising incidence of mouth cancer worldwide. For example, research published in the International Journal of Cancer claims that researchers at Queen Mary University of London have developed the first-ever PCR test for mouth cancer. Such developments are anticipated to present lucrative growth opportunities for the major players in the Global Oral Cancer Rapid Test Kit Market during the period in analysis.

Impact of Escalating Geopolitical Tensions on Global Oral Cancer Rapid Test Kit Market

The escalating geopolitical tensions disrupted the growth of the Global Oral Cancer Rapid Test Kit Market. For instance, Ukraine has a high cancer burden with approximately 160,000 newly diagnosed patients with cancer each year. However, Russia's invasion of Ukraine resulted in significant damage to medical infrastructure and the migration of both healthcare professionals and cancer patients to neighboring countries. The inaccessibility of medical services led to a significant decline in cancer diagnoses, including oral cancer. Palestine witnessed a similar situation as well when Israel's military occupation of the country resulted in the shutting down of Gaza's only cancer hospital due to a fuel shortage.

Global Oral Cancer Rapid Test Kit Market

Segmental Coverage

Global Oral Cancer Rapid Test Kit Market - By Type

Based on type, the Global Oral Cancer Rapid Test Kit Market is divided into OncAlert oral cancer LAB, lab on a chip, and Prevo-check. OncAlert Oral Cancer LAB holds the largest share in the Global Oral Cancer Rapid Test Kit Market and is anticipated to register a high CAGR during the forecast period as well. This affordable test is simple to use, does not require intrusive procedures from the patient, and gives physicians findings that are straightforward to understand. All adults can benefit from the precise, affordable tests, but high-risk groups-such as those who use tobacco products now or in the past, drink excessively, or have HPV-16-may benefit most.

Global Oral Cancer Rapid Test Kit Market - By Region

The in-depth research report on the Global Oral Cancer Rapid Test Kit Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Oral Cancer Rapid Test Kit Market owing to its high cancer screening rate and high concentration of leading industry players, including Viome, Abbott Laboratories, and Thermo Fisher Scientific Inc. Asia Pacific and Europe are anticipated to register significant growth rates during the forecast period as well owing to the increasing prevalence of oral cancer in these regions.

Competitive Landscape

Major players operating in the Global Oral Cancer Rapid Test Kit Market include Viome Life Sciences, Vigilant Biosciences, Grail, Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Quidel Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Henry Schein, Inc, Becton, Dickinson and Company, and Quest Diagnostics Incorporated.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Oral Cancer Rapid Test Kit Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Oral Cancer Rapid Test Kit Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Oral Cancer Rapid Test Kit Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing Incidence of Oral Cancer
    • 3.2.1.2. Advancements in Diagnostic Technologies
    • 3.2.1.3. Growing Emphasis on Cancer Screening Programs
  • 3.2.2. Restraints
    • 3.2.2.1. Affordability and Accessibility
    • 3.2.2.2. Competition with Conventional Diagnostic Methods
  • 3.2.3. Opportunities
    • 3.2.3.1. Growing Awareness Programs
    • 3.2.3.2. Technological Advancements
  • 3.2.4. Challenges
    • 3.2.4.1. Regulatory Approvals and Standardization
    • 3.2.4.2. Limited Sensitivity and Specificity
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Oral Cancer Rapid Test Kit Market: Marketing Strategies

5. Global Oral Cancer Rapid Test Kit Market Overview

• 5.1. Market Type & Forecast, 2019-2030
  • 5.1.1. By Value (USD Million)
• 5.2. Market Share and Forecast
  • 5.2.1. By Type
    • 5.2.1.1. OncAlert Oral Cancer LAB
    • 5.2.1.2. Lab on Chip
    • 5.2.1.3. Prevo-Check
  • 5.2.2. By End User
    • 5.2.2.1. Hospitals
    • 5.2.2.2. Diagnostic Centers
    • 5.2.2.3. Research Centers
    • 5.2.2.4. Others
  • 5.2.3. By Region
    • 5.2.3.1. North America
    • 5.2.3.2. Europe
    • 5.2.3.3. Asia Pacific (APAC)
    • 5.2.3.4. Latin America (LATAM)
    • 5.2.3.5. Middle East and Africa (MEA)

6. North America Oral Cancer Rapid Test Kit Market

• 6.1. Market Type & Forecast, 2019-2030
  • 6.1.1. By Value (USD Million)
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
    • 6.2.3.1. United States
    • 6.2.3.1.1. By Type
    • 6.2.3.1.2. By End User
    • 6.2.3.2. Canada
    • 6.2.3.2.1. By Type
    • 6.2.3.2.2. By End User

7. Europe Oral Cancer Rapid Test Kit Market

• 7.1. Market Type & Forecast, 2019-2030
  • 7.1.1. By Value (USD Million)
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
    • 7.2.3.1. Germany
    • 7.2.3.1.1. By Type
    • 7.2.3.1.2. By End User
    • 7.2.3.2. United Kingdom
    • 7.2.3.2.1. By Type
    • 7.2.3.2.2. By End User
    • 7.2.3.3. Italy
    • 7.2.3.3.1. By Type
    • 7.2.3.3.2. By End User
    • 7.2.3.4. France
    • 7.2.3.4.1. By Type
    • 7.2.3.4.2. By End User
    • 7.2.3.5. Spain
    • 7.2.3.5.1. By Type
    • 7.2.3.5.2. By End User
    • 7.2.3.6. Belgium
    • 7.2.3.6.1. By Type
    • 7.2.3.6.2. By End User
    • 7.2.3.7. Russia
    • 7.2.3.7.1. By Type
    • 7.2.3.7.2. By End User
    • 7.2.3.8. The Netherlands
    • 7.2.3.8.1. By Type
    • 7.2.3.8.2. By End User
    • 7.2.3.9. Rest of Europe
    • 7.2.3.9.1. By Type
    • 7.2.3.9.2. By End User

8. Asia Pacific Oral Cancer Rapid Test Kit Market

• 8.1. Market Type & Forecast, 2019-2030
  • 8.1.1. By Value (USD Million)
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
    • 8.2.3.1. China
    • 8.2.3.1.1. By Type
    • 8.2.3.1.2. By End User
    • 8.2.3.2. India
    • 8.2.3.2.1. By Type
    • 8.2.3.2.2. By End User
    • 8.2.3.3. Japan
    • 8.2.3.3.1. By Type
    • 8.2.3.3.2. By End User
    • 8.2.3.4. South Korea
    • 8.2.3.4.1. By Type
    • 8.2.3.4.2. By End User
    • 8.2.3.5. Australia & New Zealand
    • 8.2.3.5.1. By Type
    • 8.2.3.5.2. By End User
    • 8.2.3.6. Indonesia
    • 8.2.3.6.1. By Type
    • 8.2.3.6.2. By End User
    • 8.2.3.7. Malaysia
    • 8.2.3.7.1. By Type
    • 8.2.3.7.2. By End User
    • 8.2.3.8. Singapore
    • 8.2.3.8.1. By Type
    • 8.2.3.8.2. By End User
    • 8.2.3.9. Vietnam
    • 8.2.3.9.1. By Type
    • 8.2.3.9.2. By End User
    • 8.2.3.10. Rest of APAC
    • 8.2.3.10.1. By Type
    • 8.2.3.10.2. By End User

9. Latin America Oral Cancer Rapid Test Kit Market

• 9.1. Market Type & Forecast, 2019-2030
  • 9.1.1. By Value (USD Million)
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
    • 9.2.3.1. Brazil
    • 9.2.3.1.1. By Type
    • 9.2.3.1.2. By End User
    • 9.2.3.2. Mexico
    • 9.2.3.2.1. By Type
    • 9.2.3.2.2. By End User
    • 9.2.3.3. Argentina
    • 9.2.3.3.1. By Type
    • 9.2.3.3.2. By End User
    • 9.2.3.4. Peru
    • 9.2.3.4.1. By Type
    • 9.2.3.4.2. By End User
    • 9.2.3.5. Rest of LATAM
    • 9.2.3.5.1. By Type
    • 9.2.3.5.2. By End User

10. Middle East & Africa Oral Cancer Rapid Test Kit Market

• 10.1. Market Type & Forecast, 2019-2030
  • 10.1.1. By Value (USD Million)
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
    • 10.2.3.1. Saudi Arabia
    • 10.2.3.1.1. By Type
    • 10.2.3.1.2. By End User
    • 10.2.3.2. UAE
    • 10.2.3.2.1. By Type
    • 10.2.3.2.2. By End User
    • 10.2.3.3. Qatar
    • 10.2.3.3.1. By Type
    • 10.2.3.3.2. By End User
    • 10.2.3.4. Kuwait
    • 10.2.3.4.1. By Type
    • 10.2.3.4.2. By End User
    • 10.2.3.5. South Africa
    • 10.2.3.5.1. By Type
    • 10.2.3.5.2. By End User
    • 10.2.3.6. Nigeria
    • 10.2.3.6.1. By Type
    • 10.2.3.6.2. By End User
    • 10.2.3.7. Algeria
    • 10.2.3.7.1. By Type
    • 10.2.3.7.2. By End User
    • 10.2.3.8. Rest of MEA
    • 10.2.3.8.1. By Type
    • 10.2.3.8.2. By End User

11. Competitive Landscape

• 11.1. List of Key Players and Their Offerings
• 11.2. Global Oral Cancer Rapid Test Kit Market Share Analysis, 2023
• 11.3. Competitive Benchmarking, By Operating Parameters
• 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Geopolitical Tensions on Global Oral Cancer Rapid Test Kit Market

13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

• 13.1. Viome Life Sciences
• 13.2. Vigilant Biosciences
• 13.3. Grail
• 13.4. Abbott Laboratories
• 13.5. F. Hoffmann-La Roche AG
• 13.6. Siemens Healthineers AG
• 13.7. Thermo Fisher Scientific Inc.
• 13.8. Quidel Corporation
• 13.9. Bio-Rad Laboratories, Inc.
• 13.10. Danaher Corporation
• 13.11. Henry Schein, Inc
• 13.12. Becton, Dickinson and Company
• 13.13. Quest Diagnostics Incorporated
• 13.14. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

• 15.1. Qualitative Research
  • 15.1.1. Primary & Secondary Research
• 15.2. Quantitative Research
• 15.3. Market Breakdown & Data Triangulation
  • 15.3.1. Secondary Research
  • 15.3.2. Primary Research
• 15.4. Breakdown of Primary Research Respondents, By Region
• 15.5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable